{
    "eid": "2-s2.0-85073994873",
    "title": "Tumor necrosis factor alpha (TNF-\u03b1) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis",
    "cover-date": "2019-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Disability",
        "MSSS",
        "Multiple sclerosis",
        "sTNFR1",
        "sTNFR2",
        "Tumor necrosis factor alpha"
    ],
    "authors": [
        "Claudia Mara Ribeiro",
        "Sayonara Rangel Oliveira",
        "Daniela Frizon Alfieri",
        "Tamires Flauzino",
        "Damacio Ram\u00f3n Kaimen-Maciel",
        "Andr\u00e9a Name Colado Sim\u00e3o",
        "Michael Maes",
        "Edna Maria Vissoci Reiche"
    ],
    "citedby-count": 24,
    "ref-count": 53,
    "ref-list": [
        "Immunology of multiple sclerosis",
        "A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF",
        "Differential TNF-signaling in chronic inflammatory disorders",
        "The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor",
        "TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects",
        "Tumor necrosis factor \u03b1 and regulatory T cells in oncoimmunology",
        "TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination",
        "A new venue of TNF targeting",
        "Selective modulation of TNF-TNFRs signaling: insights for multiple sclerosis treatment",
        "Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis",
        "Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis",
        "Genetic, immune-inflammatory, and oxidative stress biomarkers as predictors for disability and disease progression in multiple sclerosis",
        "Cytokine profile in patients with progressive multiple sclerosis and its association with disease progression and disability",
        "Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis",
        "The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barre syndrome",
        "Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis",
        "Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2",
        "TNF neutralization in MS\u2014results of a randomized, placebo controlled multicenter study",
        "TNFR signaling and its clinical implications",
        "Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria",
        "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)",
        "Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity",
        "Serum NSE level and disability progression in multiple sclerosis",
        "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)",
        "Standards of medical care in diabetes\u20132014",
        "American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement",
        "Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes",
        "Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications",
        "Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF",
        "Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways",
        "Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS",
        "Targeting sTNF/TNFR1 signaling as a new therapeutic strategy",
        "Age and disability accumulation in multiple sclerosis",
        "Predicting the profile of increasing disability in multiple sclerosis",
        "TNFR1-induced NF-B, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells",
        "TNFR1-induced activation of the classical NF-\u03baB pathway",
        "Activation of caspase-8 by tumor necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygen-glucose deprived cultured cortical cells",
        "Tumor necrosis factor- antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury",
        "Cytokines in multiple sclerosis: from bench to bedside",
        "Cytokine changes during interferon\u2013beta therapy in multiple sclerosis: correlation with interferon dose and MRI response",
        "TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1",
        "Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis",
        "Sexual disparities in the incidence and course of MS",
        "Defining the clinical course of multiple sclerosis: the 2013 revisions",
        "Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients",
        "Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis",
        "Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments",
        "Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination",
        "Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis",
        "Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review)",
        "Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients",
        "Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci",
        "TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "112490164",
            "affilname": "University of Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112490164",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "108978629",
            "affilname": "Santa Casa de Londrina Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/108978629",
            "affiliation-country": "Brazil"
        }
    ],
    "funding": [
        "State University of Londrina",
        "Coordination for the Improvement of Higher Level of Education Personnel",
        "CNPq"
    ]
}